As an advance over the existing literature, the present review provides an up-to-date and comprehensive overview of the regulatory mechanisms that govern HOTAIR expression during BC development, its role in driving BC metastasis and drug resistance, and its potential as a therapeutic target. Here, HOTAIR is linked to breast cancer.